Under this context, the insertion of specific genes that inhibit virulence factors in the pathogen, enhance natural defense mechanisms in the host, and/or encode antimicrobial peptides (AMPs) may have some potential to develop GMCs with resistance against bacterial diseases [31,32,33,34,35,36,37]. The gene discussed is ADSL; the disease is bacterial infectious disease.